HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by WATSON, W. J. Search for Related Content PubMed PubMed Citation Articles by WATSON, W. J.

Serial Changes in the 50-g Oral Glucose Test in Pregnancy: Implications for Screening

From the USA Hospital Berlin, APO New York, New York

Abstract

To quantitate the effect of advancing pregnancy on the screening test for gestational diabetes, 550 patients were given a 50-g oral glucose screening test at 20, 28, and 34 weeks' gestation. A significant increase in the plasma glucose value was found, with a mean increase of 1.1 ± 1.9 mg/dL per week from 20-34 weeks' gestation (r = 0.39, P < .001). Only 34 patients (6.2%) had a positive screening test at 20 weeks' gestation, and it appears that routine screening in a low-risk population at 20 weeks is not warranted. Sixty patients (10.9%) with a negative screening test at 20 weeks had a positive test at 28 weeks. Forty-four patients (8.0%) with a negative test at 28 weeks had a subsequent positive test at 34 weeks. The overall incidence of gestational diabetes in this population was 4.9%. Currently, screening is recommended at 24-28 weeks for all pregnancies that have not been previously identified as having glucose intolerance. Eleven percent of the gestational diabetics in our population would have been undetected had we screened only at 24-28 weeks. This quantitative information may be helpful in deciding whether rescreening later in pregnancy is indicated.

This article has been cited by other articles:

				D. A. Sacks, W. Chen, G. Wolde-Tsadik, and T. A. Buchanan Fasting Plasma Glucose Test at the First Prenatal Visit as a Screen for Gestational Diabetes Obstet. Gynecol., June 1, 2003; 101(6): 1197 - 1203. [Abstract] [Full Text] [PDF]

				A. Ferrara, M. M. Hedderson, C. P. Quesenberry, and J. V. Selby Prevalence of Gestational Diabetes Mellitus Detected by the National Diabetes Data Group or the Carpenter and Coustan Plasma Glucose Thresholds Diabetes Care, September 1, 2002; 25(9): 1625 - 1630. [Abstract] [Full Text] [PDF]